
https://www.science.org/content/blog-post/article-shows-med-chem-like
# An Article That Shows What Med-Chem Is Like? (January 2013)

## 1. SUMMARY

This 2013 blog post from Science magazine is not a research article, but rather a query posed to the readership asking for recommendations of journal articles or book chapters that would best illustrate "what medicinal chemistry and drug discovery are really like." The author acknowledges that this is challenging because the real-world experience of drug discovery doesn't always translate well to academic publications.

The piece is essentially a call for suggestions from practitioners in the field, recognizing that the practical realities of medicinal chemistry—including the iterative nature of optimization, the high failure rates, and the complex decision-making involved—may not be adequately captured in traditional scientific literature.

## 2. HISTORY

Subsequent to this 2013 post, there was significant evolution in how drug discovery realities are communicated:

**Educational Initiatives**: Pharmaceutical companies and academic institutions increasingly developed case-study-based curricula that expose students to real drug discovery campaigns, including both successes and failures. Programs like the ACS Medicinal Chemistry Division's educational resources became more focused on practical examples.

**Clinical Failure Transparency**: The period saw growing emphasis on publishing negative results and failed clinical trials. Initiatives like the AllTrials campaign (founded 2013) pushed for greater transparency in clinical research, making it easier for students and researchers to access data on what drug discovery "really looks like" when things don't work.

**Open Access to Drug Discovery Data**: Companies began releasing more comprehensive datasets of their drug discovery efforts, including the ChEMBL database expansions and various pharmaceutical company datasets that showed the full trajectory of medicinal chemistry programs, not just the successful outcomes.

**Industry-Academia Partnerships**: Increased collaboration between pharmaceutical companies and universities led to more realistic training programs that expose students to actual drug discovery workflows, including the iterative optimization cycles and decision-making processes that characterize real-world medicinal chemistry.

## 3. PREDICTIONS

**Prediction (implicit)**: That the field needed better ways to teach the realities of drug discovery beyond traditional academic publications.

**Outcome**: Partial success. The subsequent decade saw significant improvements in case-study-based education, greater transparency in publishing negative results, and more comprehensive databases showing real drug discovery trajectories. However, the fundamental tension between academic publication priorities and industrial drug discovery realities persists.

## 4. INTEREST

Rating: **3/10**

While the query addresses an important educational challenge in medicinal chemistry training, the post itself is essentially a discussion prompt rather than substantive analysis or reporting, limiting its long-term significance for understanding the biotechnology industry.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20130104-article-shows-med-chem-like.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_